Activaero is the global technology leader in controlled breathing technologies for inhaled therapeutics. With approved, stand alone inhalation products and inhalation systems available for clinical trials and marketing partnerships, Activaero’s technologies allow for the most precise and efficient patient-tailored pulmonary delivery.

Activaero was acquired by Vectura in 2014.

Menu